Life Science and Analytical Instruments Market Demand, Services and Future Outlook

 Life Science Analytical Instruments Market Overview

Market Research Future (MRFR) reveals that the life science analytical instruments market 2020 can presumably accrue a CAGR of 6.8% between 2018 and 2025 (evaluation period). The global market is also anticipated to touch USD 91,662.4 Million by 2025, adds MRFR. We will provide COVID-19 impact analysis with the report, along with all the key developments since the coronavirus disease outbreak.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/825

Life Science Analytical Instruments Market Key Drivers and Barriers

Pharma companies are grappling with the challenges posed by the COVID-19 outbreak, by trying to fulfill the growing demand for vital medical products among patients. Apart from this, companies are also tasked with the job of creating advanced therapeutics as well as vaccines to treat SARS-CoV-2. The situation has been aggravated by the massive disruption to the supply chains and manufacturing units, while many of the workers are trying to adjust to the remote working model post the lockdown. This has drastically affected the lab capacity worldwide. The life science industry is presently focused on developing treatments and vaccines for the novel coronavirus, while also boosting the production of ventilators, pumps and diagnostic devices.

On the other hand, the pandemic has been opportune for the consumer health segment of the life sciences industry, as more and more consumers are stocking up on various over-the-counter medicines along with sanitizers. In the long run, the life science analytical instruments market can emerge stronger, in light of the rising interest of consumers in items that support hygiene, health and wellbeing. Another major trend in recent times can be the escalated use of digital technologies, altering the way healthcare professionals interact with patients by facilitating better care. Speaking of digital technologies, drones are observing rampant demand in the healthcare industry, as they are used for delivering various drugs with self-administration potential.

Analytical instruments have captured a considerable share in the global market over the years, following the expanding patient populace with diabetes, heart-related issues and cancer. This scenario has boosted the need for accurate and advanced diagnostic analytical tools. The massive pool of middle and small-sized firms in the market like Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Qiagen N.V. and Bio-Rad Laboratories, Inc., design and offer a variety of analytical instruments that accurately diagnose diseases, while providing efficient patient care with high speed and ease of use.

Life Science Analytical Instruments Market Segmental Insight

The Life Science Analytical Instruments market has been dissected in terms of type, application, and end-user.

The types covered in the market study include centrifuges, spectroscopy, microscopy, cell counting, next-generation sequencing, flow cytometry, electrophoresis, PCR, chromatography, and more.

Clinical and diagnostics applications, research applications and others are the main applications of life science analytical instruments.

With respect to the end-user segment, the market caters to pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, among others.

Life Science Analytical Instruments Market Regional Study

The Life Science Analytical Instruments industry can be geographically considered for Asia-Pacific/APAC, the Americas, the Middle East Africa/MEA and Europe.

In the coming years, the Americas can take the lead in the global market for life science analytical instruments. The market growth in the Americas is the outcome of the drastic surge in the cases of chronic diseases, such as cancer and HIV. The rising number of lifestyle-based disorders, technological innovations in diagnostic systems, and the burgeoning elderly population in the region also adds to the growth momentum of the market.

Europe is expected to be the second highest gainer in the global market, with major growth to be observed in the Western and Eastern parts of the region. The Western European market is advancing rapidly in Germany, Italy, the UK, France, and Spain. Some of the key growth boosters in the market could be the thriving pharmaceutical and biotechnology industry along with the frequent number of clinical trials taking place in the region. The vast pool of academic organizations and research institutions present in the region also accelerates the market growth to a large extent.

With the fastest growth rate, the APAC market is racing ahead relentlessly thanks to the alarming rise in the cases of chronic disorders and acute diseases like HIV, diabetes and cancer. Given the huge number of proactive research organizations focused on clinical trials coupled with the constant upgradation of the healthcare infrastructure also fuels the growth of the life science and analytical instruments market.

The MEA market could potentially witness a steady growth in the global life science analytical instruments market. However, it is the Middle East that could secure the top position, on account of the emerging countries like Saudi Arabia, Egypt, and more. Across these countries, the healthcare infrastructure is improving steadily, which can help the region maintain its global position.

Life Science Analytical Instruments Industry Leading Competitors

Leading competitors in the worldwide industry include Qiagen (Germany), Merck KGAA (Germany), Danaher (US), PerkinElmer, Inc. (the US), Shimadzu Corporation (Japan), Becton, Dickinson and Company (US), Agilent Technologies, Inc (US), General Electric Company (US), Bio-Rad Laboratories, Inc.(US), Thermo Fisher Scientific (US), to list a few.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/life-science-analytical-instruments-market-825

Life Science Analytical Instruments Market Latest Updates

Scientists from the Air Force Research Laboratory, along with the Intelligence Advanced Research Projects Activity and University of Michigan-based researchers have created a chemical sensing device that is based on a gas chromatograph. This device helps detect ARDS/acute respiratory disease syndrome that is related to SARS-CoV-2.

Browse Related Research Reports at:

Cold Pain Therapy Market Research Report - Forecast to 2023 | MRFR

Chronic Lymphocytic Leukemia Treatment Market Size and Share | Forecast to 2023

Global Coronary Stents Market Demand, Size, Share, Growth, Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Osteosarcoma Market Key Companies Profile, Research and Insights

 Market Highlights

The global osteosarcoma market is expected to grow at a CAGR of 6.40% during the forecast period 2017-2023. Osteosarcoma is a bone tumor that may occur in any bone of the body. Approximately 75% of cases, patients with osteosarcoma are between 15-25 years old. Male are more as often suffer from osteosarcoma than females.

Currently, chemotherapy for osteosarcoma is usually directed within prospective clinical trials. In drug treatment, doxorubicin is the first and most commonly used the drug for osteosarcoma patients. Cisplatin is the second most commonly used drug and is included in most of the protocols. High-dose methotrexate with leucovorin is the third most commonly used drug. These treatment methods are likely to boost the pharmaceutical industries resulting in the growth of the osteosarcoma market.

Taste the market data and market information presented through more than 128 market data tables and figures spread over 134 pages of the project report. Avail the in-depth table of content TOC market synopsis on “Osteosarcoma market research report–Global forecast till 2023.”

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4412

Major Players in the Osteosarcoma Market

Some of the key players in the global market are Pfizer (U.S.), Novartis (U.S.), Spectrum Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals (U.K), Baxter (U.S.), Advaxis Inc., Bellicum Pharmaceuticals (U.S.), and Inc. Isofol Medical AB (Sweden).

Regional Analysis

The global osteosarcoma market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East Africa.

Constantly increasing the patient population of cancer, increasing the number of cases in children, and increasing government support for research in the healthcare domain drive the Americas market growth and remains responsible for making it one of the largest global market.

Europe holds the second position in the market due to increasing development and more focus on healthcare domain. Countries such as Germany and France are investing more in research development to develop new treatment methods for various types of cancer. According to the European Cancer Organization, incidence rates of cancer diseases including osteosarcoma have increased by 41% and 50% respectively between 1993-1995 and 2012-2014. It is one of the major factors responsible for the growth of the market in this region.

The Asia Pacific is expected to be the fastest growing region in the global osteosarcoma market owing to emerging player and focus of established players in this region. Moreover, developing countries such as India, China, and the Republic of Korea are focusing on research development and minimizing barriers to drug approval, which is projected to boost the market growth in this region.

On the other hand, the Middle East Africa owns the minimum market share of the osteosarcoma market due to less development in the healthcare services such as new and advanced diagnosis treatment methods in healthcare domain.

Segmentation

The global osteosarcoma market is segmented on the basis of types, diagnosis, treatment, and end user.

On the basis of the types, it is further segmented into intramedullary osteosarcoma, juxtacortical osteosarcoma, and extra-skeletal osteosarcoma.

On the basis of the diagnosis, the market is segmented into biopsy, X-ray, MRI, CT Scan, bone scan, and others.

On the basis of the treatment, the market is segmented into chemotherapy, surgery, radiation therapy, and others.

On the basis of the end user, the market is segmented into hospitals clinics, cancer research centers, and others.

Table Of Content 

Chapter 1. Report Prologue 

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Technology Trends Assessment

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/osteosarcoma-market-4412

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Pricing Analysis

Chapter 6. Global Osteosarcoma Market, By Type Of Service

Browse Related Research Reports at:

Keloid Treatment Market | Therapeutics, Size, Growth and Forecast To 2023

Controlled Release Drug Delivery Market Share, Trends, Size and Industry Forecast to 2023

Cold Pain Therapy Market Research Report - Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Amniotic Membrane Market Sales, Cost, Profit and Insights

 Market Highlights:

Amniotic Membrane is the inner layer of the placenta, which possesses various biological properties used to various defects, such as disorders of the outer eye, partial stem cell deficiency, corneal defects, chemical burns, conjunctivochalasis, pterygium, symblepharon, and various other ocular surface conditions. Amniotic membrane is used in various applications, such as regenerative medicine, ophthalmology, surgical wounds, and stem cell biology.

The Global Amniotic Membrane market is estimated to lead a healthy growth. The Global Amniotic Membrane market is majorly driven by increasing number of market players focusing on various applications of Amniotic Membrane, rising global aging population, increasing patient population, and rising healthcare expenditure. Varied applications of amniotic membrane are likely to drive the growth of global amniotic membrane market.

Additionally, rise in the number of amniotic membrane transplant performed, need for better and newer technologies, and improved healthcare facilities are propelling the growth of Global Amniotic Membrane market. Factors such as socio-ethical concerns and lack of awareness among mass is likely to hamper the growth of the Global Amniotic Membrane market. Global Amniotic Membrane market is expected to grow at a CAGR of 9.8% during the forecast period.

Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/5645

Regional Analysis:

The Americas dominate the Global Amniotic Membrane market owing to the rising market players focusing on varied applications of amniotic membrane; the increasing geriatric population also leads to rising patient population. Additionally, rising number of amniotic membrane transplant and wide availability of medical device manufacturers and pharmaceutical biotechnology companies are fuelling the growth of global amniotic membrane market. According to CDC, around 19.6% population in the U.S. is likely to be 56 years and older. This rising aging population will increase the patient population leading to growth in amniotic membrane market.

Europe accounts for a healthy market share due to factors such as rising healthcare networks and growing healthcare expenditure. Growing healthcare market and infrastructure is driving the Amniotic Membrane market in Europe. Additionally, according to Eurostat, Germany incurred healthcare expenditure over EUR 321 billion in 2014. Germany, France, and the U.K hold a significant share in the market due to the increasing demand for technologically advanced devices and treatment.

The Asia Pacific is expected to register the fastest growing rate for the Amniotic Membrane market. High growth rate is attributed to rising healthcare centers, skilled medical professionals, and rising standard of living. Additionally, rising patient population and demand for newer and better treatment is fuelling the market growth. India and China are the major contributors to the market growth due to the rapid development of healthcare sector and increasing healthcare infrastructure in these regions and increasing demand for new treatment services.

The Middle East Africa is expected to witness limited growth due to limited access to healthcare services. In the Middle East, the growth of the market is driven by increasing healthcare infrastructre and demand for enhanced patient safety.

Key players

• Derma Sciences Inc.

• FzioMed, Inc.

• Alliqua BioMedical

• Skye Biologics Inc.

• IOP Ophthalmics

• Amniox Medical, Inc.

• MiMedx Group, Inc.

• Human Regenerative Technologies, LLC

• Tissue-Tech Inc.

• APPLIED BIOLOGICS

• Amnio Technology

Segments:

The Global Amniotic Membrane market is segmented on the basis of type, application, and end-users. On the basis of type, the amniotic membrane market is segmented as lyophilized amniotic membrane, cryopreservation amniotic membrane, and others. On the basis of application, the amniotic membrane market is segmented into ophthalmology, surgical wounds, stem cell biology, and regenerative medicine.  On the basis of end-user the market is segmented into specialized clinics centers, hospitals, ambulatory surgical centers, research institutes, and laboratory.

BRIEF TOC:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/amniotic-membrane-market-5645

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends Assessment

…TOC CONTINUED

Browse Related Research Reports at:

Type 2 Diabetes Mellitus Treatment Market Research Report - Forecast to 2023 | MRFR

Hemophilia Treatment Market Overview, Size, Share, Growth and Industry Trends

Global Bariatric Surgery Market Size, Trends, Growth 2017-2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Spectral Computed Tomography (CT) Market Market Profile, Opportunities, Global Industry Analysis

 Spectral computed tomography (SCT) is referred to as a scanning technique which separates the energy into two or more energy bands in place of using one broad energy band of x-rays. The introduction of spectral computed tomography has transformed the diagnostic system by providing the radiologists a clearer view of any type of discrepancies in the organs of the body.

Competitive Dashboard:

The prominent players operating the global spectral computed tomography (CT) market are Trivitron Healthcare (U.S.), Pall Corporation (U.S.), Cleaver Scientific Ltd (U.K.), iCAD Inc. (U.S.), Siemens Healthcare Private Limited (Germany), PerkinElmer Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp (U.S.), Bio-Rad Laboratories Inc. (U.S.), Hitachi medical corporation (Japan), Shenzhen Anke High-tech Co. Ltd. (China), Xoran Technologies LLC (U.S.), Neusoft Medical Systems (Russia), Varian Medical Systems Inc.  (U.S.), Thermo Fisher Scientific (U.S.), Shimadzu Corporation (Japan), Agilent Technologies (U.S.), and General Electric Company (U.S.).

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1026

Market Drivers and Restraint:

Spectral computed tomography is an upcoming scanning technique which may overshadow the applications of conventional computed tomography. Computed tomography holds a prominent place in medical imaging. It possesses the ability to create pictures of internal anatomy and transform them to film through diagnostic imaging. With growing incidences of cardiac diseases, orthopedic diseases, neurological diseases, and others, the global market for spectral computed tomography has flourished. The growing geriatric population, rapid advancements in the medical imaging devices, and launch of latest products have further propelled the market growth during the review period. The rise in unknown and novel diseases is also favoring the demand for clearer imaging techniques, thus fostering the market growth.

On the flip side, market saturation in the developed countries coupled with the adverse effects of X-rays is considered to impede the market growth in the coming years. Moreover, the high cost of the devices and lack of skilled physicians are anticipated to retard the market growth.

Industry Updates:

A leading global player in health technology, Royal Philips, in collaboration with the Singapore Institute of Advanced Medicine Holdings has officially opened the Advanced Medicine Imaging center at Biopolis, Singapore, which is recognized as an international biomedical research hub. Besides offering scientific RD, specialized oncology care, and medical training for up-skilling the healthcare professionals, the facility is equipped with Philips’ IQon Spectral CT, a new generation Computed Tomography (CT).

Koninklijke Philips N.V. is one of them by holding a major share in the Spectral Computed Tomography (CT) market. The company offers magnetic resonance imaging, diagnostic imaging solutions, computed tomography, and diagnostic X-ray. In November 2016, Philips launched Philips IQon Spectral CT in Canada.  The Philips IQon Spectral CT is the spectral detector CT which is specifically designed for spectral imaging. The product delivers on-demand colour quantification with an ability to characterize structures simply at a low dose.

Siemens Healthcare GmbH is another renowned market player in the market. The company provides medical diagnostics solutions, healthcare equipment, and related services. Siemens offers products and solutions in the areas of laboratory diagnostics, healthcare IT, hearing instruments, and infrastructure, refurbished systems, and education and training, medical accessories, electronics, and others.

General Electric Company is a leading provider of medical imaging equipment. The product portfolio of company in Computed Tomography includes Revolution Frontier, Revolution EVO, Revolution CT, Revolution HD, Optima CT540, and others. Choosing one specific niche and making considerable investments in RD as well as advertising is one of the key strategies of GE.

Segmental Analysis:

The global spectral computed tomography (CT) market has been segmented on the basis of application, type, end-user, and region.

By mode of type, the global spectral computed tomography (CT) market has been segmented into electron beam tomography, spiral CT, positron emission tomography (PET), multi-slice computed tomography, single-photon emission computed tomography, and others.

By mode of application, the global spectral computed tomography (CT) market has been segmented into neurology, oncology, spine, cardiology, body imaging, musculoskeletal disorders, and gastrointestinal diseases.

By mode of end-users, the global spectral computed tomography (CT) market has been segmented into hospitals, diagnostic centers, and others.

Spectral Computed Tomography (CT) Market – Regional analysis

Geographically, the spectral computed tomography (CT) market has been studied under America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, the American region is considered to dominate the global spectral computed tomography (CT) market due to the presence of huge patient population suffering from cardiovascular diseases, orthopedic diseases, and cancer. Moreover, the well-developed healthcare sector and the ever-increasing geriatric population have influenced the market in this region during the assessment period.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/spectral-computed-tomography-market-1026

Asia Pacific is expected to be the fastest growing region and is likely to maintain its dominance in the coming years. The growth in this region is attributed to the presence of developing economies such as China and India. Moreover, the presence of huge patient population suffering from chronic diseases and huge opportunities have contributed to the market growth.

Browse Related Research Reports at:

Nutraceutical Excipients Market Share, Applications, Industry Analysis and Forecast to 2023

Endometrial Cancer Market Application, Growth, Trends, Size | Global Industry Analysis 2023

Palliative Care Market Research Report –Global Forecast to 2023| MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research Consulting Services.

Immunoassays in R&D Market SWOT Analysis, Segmentation and Key Companies Profile

 Immunoassays in RD Market Highlights

The global immunoassays in RD market is expected to exhibit a strong 8.18% CAGR over the forecast period from 2018 to 2023 and rise to a valuation of USD 7,716.6 million, according to the latest research report from Market Research Future (MRFR). The report profiles the global immunoassay in RD market in detail and provides a comprehensive analysis of the market’s growth trajectory over the historical review period. The key factors influencing the growth of the market over the period are studied in detail in the report, providing readers with a clear look at the factors driving and restraining the immunoassays in RD market.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7892

Immunoassays are a bioanalytical tool widely used in disease diagnosis and therapeutic drug research, development, and monitoring. Immunoassays provide an accurate quantitative analysis of drug development processes and testing. The quantitative analysis provided by immunoassays is the leading driver for the global immunoassays in RD market, as more accurate, well-informed decisions can be made regarding dosage and formulations with the help of immunoassays. The increasing demand for more effective drug formulations in the pharmaceutical sector is likely to be a major driver for the global immunoassays in RD market over the forecast period. As the prevalence of diseases has grown, the demand for more effective drug development has grown stronger, leading to a growing demand from the immunoassays market.

The growing prevalence of autoimmune disorders, infectious diseases, endocrine disorders, and cancer is likely to be a major driver for the immunoassay in RD market, as these comprise major disease classes in which immunoassays are widely used for drug development and monitoring. Growing pollution and environmental problems have triggered a rise in the prevalence of autoimmune diseases in recent years, leading to a growing demand for organic, risk-free medication that can control autoimmune diseases. Cancer research has also become a major expenditure avenue for healthcare investors and is likely to remain a profitable revenue generator for the immunoassays in RD market over the forecast period.

Immunoassays in RD Market Operated Leading Players:

Leading players in the global immunoassays in RD market include Abcam plc, Sysmex Corporation, F. Hoffman-La Roche Ltd., Abbott Laboratories, bioMerieux Inc., Danaher Corporation, Becton Dickinson and Company, Siemens Healthineers, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories Inc. Developing single-use kits as well as a healthy software platform are likely to remain important agendas for players in the immunoassays in RD market over the forecast period. Growing demand for single-use pharmaceutical kits in order to ensure zero contamination is likely to drive development in the immunoassay in RD market. The growing demand for easily integrable software platforms for running immunoassay operations is also likely to be a major driver for the global immunoassay in RD market over the forecast period.

Immunoassays in RD Market Segmentation:

The global Immunoassays In RD Market is segmented on the basis of product, type, application, end user, and region.

By product type, the global immunoassays in RD market is segmented into kits and reagents, analyzers, and software and services.

By type, the global immunoassays in RD market is segmented into enzyme-linked immunosorbent assays (ELISA), enzyme-linked immunospot assay (ELISpot), chemiluminescence, fluoroimmunoassay, and others.

By application, the market is segmented into infectious diseases, cancer research, endocrinology, autoimmune diseases, and others.

By end use, the immunoassay in RD market is segmented into pharmaceutical and biotechnology companies, academic institutions and laboratories, and others.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/immunoassay-in-r-d-market-7892

Immunoassays in RD Market Regional Analysis:

The Americas is likely to be the dominant regional market for immunoassays in RD over the forecast period. The strong presence of healthcare research agencies in the region, allied to strong government funding for healthcare technology development, is likely to be a major driver for the global immunoassay in RD market over the forecast period. The growing awareness about autoimmune diseases and cancer research in the region is likely to be a major driver for the immunoassays in RD market. Europe is also likely to be a major regional market for immunoassays in RD due to the growing government support for medical research.

Browse Related Research Reports at:

Chronic Lymphocytic Leukemia Treatment Market Size and Share | Forecast to 2023

Global Coronary Stents Market Demand, Size, Share, Growth, Forecast to 2023 | MRFR

Controlled Release Drug Delivery Market Share, Trends, Size and Industry Forecast to 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Microdermabrasion Market Insights, Growth and Applications

 Market Scenario:

Microdermabrasion is an abrasive process used to gently sand the thicker and uneven layers of skin. According to the American Society for Aesthetic Plastic Surgery, microdermabrasion is used for the treatment of hyperpigmentation, acne trauma scars, photo-damage, and stretch marks. There is an increasing demand for minimally invasive cosmetic procedures which is an important driver for the growth of the market. According to the American Society of Plastic Surgeons, about 15.9 million surgical and minimally-invasive cosmetic procedures were performed in the U.S. in 2015. Additionally, development of new technologically advantaged devices, and increasing demand for cosmetics also influence the growth of the market.

Increasing number of non-surgical procedures, offering enormous benefits such as quick recovery, reduced time of treatment, and better results than other cosmetic surgical procedures is also influencing the growth of this market. Furthermore, attraction of the youth towards western lifestyle and extensive use of cosmetics for skin care accelerate the growth of the market. However, the growth of the market is restrained by the availability of alternative treatments such as chemical peel and laser skin resurfacing. The acceptance of the laser resurfacing is increasing. According to the American Society of Plastic Surgeons, the number of laser skin resurfacing procedures in 2016 reached approximately to 586,662 from 569,458 in 2015.

Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/5467

The market for global microdermabrasion is expected to reach USD 802.44 million by 2023 from USD 609.79 million in 2016, at a CAGR of 3.42% from 2017 to 2023.

Intended Audience

• Pharmaceutical companies

• Biotechnological institutes

• Research and Development (RD) Companies

• Medical Research Laboratories

• Market Research and Consulting Service Providers

Segmentation

The global microdermabrasion market is segmented on the basis type, product, indication, and end user.

On the basis of type, the market is segmented diamond microdermabrasion, crystal microdermabrasion, and others. On the basis of product, the market is categorised into microdermabrasion machine, microdermabrasion crystals, microdermabrasion tips, microdermabrasion creams and scrubs, and others. The microdermabrasion machine segment is sub-segmented into table top, hand-held, and others. The microdermabrasion crystals segment is sub-segmented into aluminium oxide crystals, sodium bicarbonate crystals, sodium chloride crystals, and others. The microdermabrasion tips segment is sub-segmented into diamond tips, bristle tips, and others.

On the basis of indication, the market is segmented into acne trauma scars, hyperpigmentation, photo-damage, stretch marks, and others. On the basis of end users, the market is segmented into hospitals, dermatology clinics, home care, and others.

Regional Analysis

The Americas dominates the global microdermabrasion market owing to increasing adoption of new technologies for addressing various dermal conditions like acne, stretch marks, hyperpigmentation, and others. Additionally, rising demands for minimally invasive procedures within the region is boosting the market growth.

Europe is the second largest market, in the global microdermabrasion market owing to increasing adoption of the technology for the treatment of skin related problems within the region. Moreover, huge patient population and rising healthcare expenditure facilitates the market growth within the region. According to the British Skin Foundation in 2016, about 60% of the British population was estimated to have suffered from some kind of the skin disease. Moreover, approximately 28% of the population within the region admitted to witness acne at some stage during their lifetime.

Asia pacific region is the fastest growing market. Increasing prevalence of acne and rising demands for minimally invasive procedures is facilitating the market growth within the region. According to the Cosmetic Physicians College of Australasia in 2015, the Australians spent approximately USD 890 million on minimally or non-invasive cosmetic procedures. The estimated rise was of 5% from 2014.

The Middle East Africa has the least share in the global microdermabrasion market due to presence of poor economies especially in the African region. Majority of the market of Middle Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the economies like Saudi Arabia, Kuwait and Qatar within the region.

TABLE OF CONTENTS

1  REPORT PROLOGUE

2  MARKET INTRODUCTION

2.1 Introduction 18

2.2 Scope Of Study 18

2.3 Research Objective 18

2.4 Assumptions Limitations 19

2.4.1 Assumptions 19

2.4.2 Limitations 19

3  RESEARCH METHODOLOGY

3.1 Primary Research Methodology 21

3.2 Secondary Research Methodology 22

3.3 Market Share Analysis 23

3.4 Trade Analysis 23

3.5 Market Pricing Approach 23

4  MARKET DYNAMICS

4.1 Introduction 24

4.2 Drivers 25

4.2.1 Increasing Prevalence Of Skin Diseases 25

4.2.2 Rising Demands For Minimally Invasive Aesthetic Procedures For The Treatment Of Skin Diseases 26

4.2.3 Growing Expenses On The Cosmetics 27

4.3 Restraints 28

4.3.1 Alternative Non-Surgical Procedures In The Market 28

4.4 Mega Trend 29

4.4.1 Hydrafacial: 29

4.5 Macroeconomic Indicators 29

5  MARKET FACTOR ANALYSIS

5.1 Porters Five Forces 30

5.1.1 Introduction 30

5.1.2 Bargaining Power Of Suppliers 31

5.1.3 Bargaining Power Of Buyers 31

5.1.4 Threat Of New Entrants 31

5.1.5 Threat Of Substitutes 31

5.1.6 Degree Of Rivalry 32

Browse Detailed TOC with COVID-19 Impact Analysis at:https://www.marketresearchfuture.com/reports/microdermabrasion-market-5467

 Key players for global microdermabrasion market

The key players for the global microdermabrasion market are Johnson Johnson Services Inc., Procter Gamble, Koninklijke Philips N.V., Altair Instruments, Silhouet-Tone, Advanced Microderm, Inc., Dermaglow, New Shining Image LLC., Lasertec Medical Service, Delasco, and others.

Browse Related Research Reports at:

Dietary Supplements in the Age of Personalized Nutrition Market Trends, Size, Share, Global Industry Forecast to 2023

Pediatric Craniosynostosis Treatment Market 2019 | Global Industry Analysis and Forecast till 2023

Myasthenia Gravis Disease Market | Therapeutics, Size, Growth and Forecast To 2023

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.